[go: up one dir, main page]

SG11201403835UA - Process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine - Google Patents

Process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine

Info

Publication number
SG11201403835UA
SG11201403835UA SG11201403835UA SG11201403835UA SG11201403835UA SG 11201403835U A SG11201403835U A SG 11201403835UA SG 11201403835U A SG11201403835U A SG 11201403835UA SG 11201403835U A SG11201403835U A SG 11201403835UA SG 11201403835U A SG11201403835U A SG 11201403835UA
Authority
SG
Singapore
Prior art keywords
phenylsulfanyl
piperazine
dimethyl
phenyl
manufacture
Prior art date
Application number
SG11201403835UA
Inventor
Kim Lasse Christensen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48744991&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201403835U(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of SG11201403835UA publication Critical patent/SG11201403835UA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG11201403835UA 2012-01-03 2012-12-20 Process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine SG11201403835UA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261582527P 2012-01-03 2012-01-03
DKPA201200006 2012-01-03
PCT/EP2012/076377 WO2013102573A1 (en) 2012-01-03 2012-12-20 Process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine

Publications (1)

Publication Number Publication Date
SG11201403835UA true SG11201403835UA (en) 2014-10-30

Family

ID=48744991

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201403835UA SG11201403835UA (en) 2012-01-03 2012-12-20 Process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine

Country Status (24)

Country Link
US (1) US9133144B2 (en)
EP (1) EP2800746B1 (en)
JP (1) JP6018644B2 (en)
KR (1) KR102008039B1 (en)
CN (1) CN104011034B (en)
AU (1) AU2012364402B2 (en)
BR (1) BR112014016322B8 (en)
CA (1) CA2860103C (en)
CL (1) CL2014001765A1 (en)
CO (1) CO7000771A2 (en)
CY (1) CY1121629T1 (en)
DK (1) DK2800746T3 (en)
HR (1) HRP20190769T1 (en)
IL (1) IL233093A (en)
LT (1) LT2800746T (en)
MX (1) MX344144B (en)
PL (1) PL2800746T3 (en)
RS (1) RS58683B1 (en)
RU (1) RU2608307C2 (en)
SG (1) SG11201403835UA (en)
SI (1) SI2800746T1 (en)
SM (1) SMT201900248T1 (en)
WO (1) WO2013102573A1 (en)
ZA (1) ZA201404881B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015044963A1 (en) 2013-09-30 2015-04-02 Cadila Healthcare Limited An amorphous vortioxetine and salts thereof
EP2878596A1 (en) * 2013-11-29 2015-06-03 LEK Pharmaceuticals d.d. Synthesis of vortioxetine via (2-(piperazine-1-yl)phenyl)lithium intermediates
EP2894154A1 (en) 2014-01-14 2015-07-15 LEK Pharmaceuticals d.d. Synthesis of vortioxetine via (2-(piperazine-1-yl)phenyl)aniline intermediates
CN103788019B (en) * 2014-01-22 2015-10-07 苏州明锐医药科技有限公司 The fertile preparation method for Xi Ting
CN103788020B (en) * 2014-01-22 2015-11-04 苏州明锐医药科技有限公司 The preparation method of vortioxetine
EA029060B1 (en) 2014-01-31 2018-02-28 Эгиш Дьёдьсердьяр Зрт. Process for the preparation of vortioxetine salts
EP2930171A1 (en) 2014-04-07 2015-10-14 LEK Pharmaceuticals d.d. Synthesis of vortioxetine via (2,4-dimethylphenyl)(2-iodophenyl)sulfane intermediate
CN104974110A (en) * 2014-04-10 2015-10-14 江苏豪森药业股份有限公司 New crystal form of 1-[2-(2,4-dimethylphenylsulfenyl)phenyl]piperazine hydrobromide, preparation method and application thereof
ES2913282T3 (en) * 2014-05-09 2022-06-01 Shanghai Syncores Tech Inc Ltd Intermediate product of vortioxetine and method of synthesis thereof
CN105254590B (en) * 2014-05-09 2019-09-03 江苏豪森药业集团有限公司 Vortioxetine hydrobromate crystal form and its preparation method and application
CN104059030B (en) * 2014-05-30 2016-05-04 镇江圣安医药有限公司 Derivative and pharmaceutical composition and the purposes of [(benzene sulfanyl)-phenyl] piperazine
CN104292183B (en) * 2014-09-29 2016-01-06 杨献美 A kind of antidepressant drug irrigates the preparation method for Xi Ting
WO2016079751A2 (en) 2014-11-17 2016-05-26 Megafine Pharma (P) Ltd. A process for preparation of vortioxetine and polymorphs thereof
EP3023417B1 (en) * 2014-11-21 2017-06-28 Dipharma Francis S.r.l. Process for the preparation of an antidepressant and the intermediates thereof
CN104356092B (en) * 2014-11-27 2017-03-22 合肥创新医药技术有限公司 Preparation method for vortioxetine
WO2016125191A2 (en) 2015-02-04 2016-08-11 Mylan Laboratories Limited Processes for the preparation of vortioxetine hydrobromide
US10227317B2 (en) 2015-02-25 2019-03-12 Lupin Limited Process for the preparation of vortioxetine
CN104650004B (en) * 2015-03-06 2017-06-06 中山万汉制药有限公司 A kind of preparation method of hydrobromic acid Vortioxetine
CN105061364A (en) * 2015-08-17 2015-11-18 河北国龙制药有限公司 Vortioxetine hydrobromide preparation method
WO2017029377A1 (en) * 2015-08-19 2017-02-23 Amneal Pharmaceuticals Company Gmbh Process for preparation of vortioxetine hydrobromide
CN106556663B (en) * 2015-09-30 2018-05-29 成都弘达药业有限公司 A kind of detection method of 1- [2- (2,4- dimethylphenylsulfanyls) phenyl] piperazines or its salt
US9820984B1 (en) 2016-07-01 2017-11-21 H. Lundbeck A/S Dosing regimens for fast onset of antidepressant effect
US10519121B2 (en) 2016-12-30 2019-12-31 Apicore Us Llc Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts
CN106831652B (en) * 2017-01-23 2019-01-11 齐鲁天和惠世制药有限公司 A kind of preparation method of Wo Saiting
CN108017595A (en) * 2017-12-20 2018-05-11 安徽源久源科技有限公司 A kind of preparation method of 1- [2- (2,5- dimethyl benzenes sulfenyl) phenyl] piperazine
US11198671B2 (en) 2018-06-20 2021-12-14 Vio Ag Pharmaceuticals S.A. One-pot organo-pseudocatalytic C—H activation approach for the preparation of vortioxetine and vortioxetine intermediate
EP3870292A4 (en) 2018-10-26 2022-11-09 The Research Foundation for The State University of New York COMBINATION OF A SPECIFIC SEROTONIN REUPSORPTION INHIBITOR AND A SEROTONIN 1A RECEPTOR PARTIAL AGONIST TO REDUCE L-DOPA-INDUCED DYSKINESIA
CN109438390A (en) * 2018-11-26 2019-03-08 合肥创新医药技术有限公司 A kind of synthetic method of hydrobromic acid Vortioxetine impurity
US12281088B2 (en) 2020-09-10 2025-04-22 Suzhou Fude Zhaofeng Biochemical Technology Co., Ltd Process for the synthesis of vortioxetine
CN112250642A (en) * 2020-10-28 2021-01-22 合肥亿帆生物制药有限公司 Preparation method of hydrobromic acid vortioxetine impurity standard substance
CN115368318B (en) * 2022-06-22 2023-11-03 山东辰龙药业有限公司 Synthesis method and application of voathixetine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07110050A (en) 1993-10-13 1995-04-25 Daikin Mfg Co Ltd Torsional vibration damping device
UA81749C2 (en) * 2001-10-04 2008-02-11 Х. Луннбек А/С Derivated of phenylpiperazine as serotonin reuptake inhibitorS
IL161966A0 (en) * 2001-12-20 2005-11-20 Lundbeck & Co As H Aryloxyphenyl and arylsulfanylphenyl
US8722684B2 (en) * 2006-06-16 2014-05-13 H. Lundbeck A/S 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
TW201033181A (en) * 2009-02-17 2010-09-16 Lundbeck & Co As H Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine

Also Published As

Publication number Publication date
EP2800746A1 (en) 2014-11-12
RS58683B1 (en) 2019-06-28
IL233093A (en) 2017-04-30
CO7000771A2 (en) 2014-07-21
SMT201900248T1 (en) 2019-07-11
SI2800746T1 (en) 2019-06-28
MX2014008052A (en) 2014-09-26
EP2800746B1 (en) 2019-04-17
LT2800746T (en) 2019-06-10
CY1121629T1 (en) 2020-07-31
CA2860103A1 (en) 2013-07-11
DK2800746T3 (en) 2019-05-20
MX344144B (en) 2016-12-07
CA2860103C (en) 2020-07-07
KR20140107357A (en) 2014-09-04
BR112014016322A2 (en) 2017-06-13
PL2800746T3 (en) 2019-07-31
RU2014131943A (en) 2016-02-27
BR112014016322A8 (en) 2017-07-04
WO2013102573A1 (en) 2013-07-11
US9133144B2 (en) 2015-09-15
BR112014016322B8 (en) 2020-12-01
HRP20190769T1 (en) 2019-06-28
CL2014001765A1 (en) 2014-10-03
CN104011034B (en) 2016-08-17
KR102008039B1 (en) 2019-08-06
JP6018644B2 (en) 2016-11-02
US20140343287A1 (en) 2014-11-20
CN104011034A (en) 2014-08-27
HK1200827A1 (en) 2015-08-14
JP2015504062A (en) 2015-02-05
AU2012364402B2 (en) 2016-10-06
IL233093A0 (en) 2014-08-03
RU2608307C2 (en) 2017-01-17
BR112014016322B1 (en) 2020-09-15
AU2012364402A1 (en) 2014-07-03
ZA201404881B (en) 2015-12-23

Similar Documents

Publication Publication Date Title
ZA201404881B (en) Process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine
EP2812298A4 (en) Improved process for the manufacture of 2,3,3,3-tetrafluoropropene
SG11201503362QA (en) Method for the production of oxazolidinone compounds
PL3263542T3 (en) Method for producing 2,3,3,3-tetrafluoropropene
PL2912030T3 (en) Improved process for manufacturing 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine
IL245805A0 (en) Process for purifying 2,5-dichlorophenol
EP2814797A4 (en) Process for 1,3,3,3-tetrafluoropropene
IL267303B (en) Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one
PL2901857T3 (en) Process for the preparation of 3-chloro-4,5,6-trifluoro-picolinonitrile
ZA201504601B (en) Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine
EP2970053A4 (en) Process for producing 2,3,3,3-tetrafluoropropene
IL236159A0 (en) Process for the production of methylbutinol
SG11201405611SA (en) Method for preparation of 2-(2,3-dimethylphenyl)-1-propanal
SG11201406708XA (en) Itq-49 material, method for the production thereof and use of same
IL238829A0 (en) Process for preparing 4-(cyclopropylmethoxy)-n-(3,5-dichloro-1-oxido-4-pyridyl)-5-methoxypyridine-2-carboxamide
PT2800746T (en) Process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine
IL229669A0 (en) Process for preparation of 1,2,3 -triazole-4-carboxamides
EP2931691A4 (en) Process for the generation of 2,5-dimethylhexene from isobutene
PL398018A1 (en) New diacylo-sn-glycero-3-phosphocholine and process for the preparation thereof
PL391832A1 (en) N-trazinylammonium salts, process for their production and the use thereof
PL399603A1 (en) Process for the preparation of 3ß, 15α-dihydroxy-5α-androst-17-one
PL398020A1 (en) New phospholipide and process for the preparation thereof
IL240819A0 (en) Process for the manufacture of moxonidine
TH1401006705A (en) Method for preparation 2-(2,3-dimethylphenyl)-1-propanal (2-(2,3-dimethylphenyl)-1-propanal)